Local Institution

Lubbock, Texas 79430-0002

0 studies enrolling now · 6 studies all time

What they study most

Diabetes Mellitus, Diabetes, Type 2, Lung Cancer, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma, Pulmonary Embolism, Rheumatoid Arthritis, Venous Thrombosis

Studies at this site

• An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer — Withdrawn before enrolling
• Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
• PPAR - Combination With Metformin — Completed
• A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control — Completed
• Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy — Completed
• BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery — Completed